ApprovalTrail

Approval · Notice of Compliance 5658 · 1994

COLESTID TABLETS: Notice of Compliance 5658

Issued September 30, 1994

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
5658
Date
September 30, 1994
Company
The Upjohn Company Of CanadaMississauga, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
New dosage form
Therapeutic class
Antihypercholesterolemic

Products in this notice

BrandDINStatus today
COLESTID TABLETS02132680Marketed

Medicinal ingredients